[HTML][HTML] An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with …
JR Johnson, D Lossignol, M Burnell-Nugent… - Journal of pain and …, 2013 - Elsevier
Context Chronic pain in patients with advanced cancer poses a serious clinical challenge.
The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US Adopted …
The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US Adopted …
[引用][C] An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients …
JR Johnson, D Lossignol… - Journal of pain and …, 2012 - difusion.ulb.ac.be
An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With …
JR Johnson, D Lossignol… - Journal of Pain and …, 2013 - research.ed.ac.uk
CONTEXT: Chronic pain in patients with advanced cancer poses a serious clinical
challenge. The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US …
challenge. The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US …
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal …
JR Johnson, D Lossignol… - Journal of Pain and …, 2012 - europepmc.org
Objectives This follow-up study investigated the long-term safety and tolerability of THC/CBD
spray and THC spray in relieving pain in patients with advanced cancer. Methods In total, 43 …
spray and THC spray in relieving pain in patients with advanced cancer. Methods In total, 43 …
[引用][C] An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients …
JR JOHNSON, D LOSSIGNOL… - Journal of pain and …, 2013 - pascal-francis.inist.fr
An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD
Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related …
Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related …
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal …
JR Johnson, D Lossignol, M Burnell-Nugent… - Journal of Pain and …, 2013 - hero.epa.gov
CONTEXT: Chronic pain in patients with advanced cancer poses a serious clinical
challenge. The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US …
challenge. The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US …
An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With …
JR Johnson, D Lossignol, M Burnell-Nugent… - Journal of Pain and …, 2013 - infona.pl
Chronic pain in patients with advanced cancer poses a serious clinical challenge. The Δ9-
tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US Adopted Name …
tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US Adopted Name …
An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With …
JR Johnson, D Lossignol… - Journal of Pain and …, 2013 - jpsmjournal.com
Context Chronic pain in patients with advanced cancer poses a serious clinical challenge.
The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US Adopted …
The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US Adopted …
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal …
JR Johnson, D Lossignol, M Burnell-Nugent, MT Fallon - 2013 - pubmed.ncbi.nlm.nih.gov
Context Chronic pain in patients with advanced cancer poses a serious clinical challenge.
The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US Adopted …
The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US Adopted …